The North America molecular diagnostics market has been segmented based on products, test location, application, technology and geography. The product segment includes instruments, reagents and others. Application segment analyzed in this study include oncology, pharmacogenomics, infectious disease testing, genetic testing, neurological disease, cardiovascular disease, microbiology and others. Technology is segmented into PCR, In-situ hybridization, sequencing, chips and microarrays, INAAT, mass spectrometry, transcription mediated amplification and others. Test location segment includes point of care, OTC or selftests and central laboratories. In addition, country-wise market estimates and forecasts for all the previously mentioned segments have been included.